4//SEC Filing
Olson William C 4
Accession 0001441844-11-000029
CIK 0000835887other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:57 PM ET
Size
11.5 KB
Accession
0001441844-11-000029
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Exercise/Conversion
Common Stock
2011-07-01$5.46/sh+6,335$34,589→ 51,609 total - Award
Non-Qualified Stock Option (right to buy)
2011-07-01+70,000→ 70,000 totalExercise: $7.40From: 2012-07-01Exp: 2021-07-01→ Common Stock (70,000 underlying) - Tax Payment
Common Stock
2011-07-01$7.40/sh−5,276$39,042→ 46,333 total - Exercise/Conversion
ESPP (right to buy)
2011-07-01−6,335→ 0 totalExercise: $5.46From: 2011-07-01Exp: 2011-07-01→ Common Stock (6,335 underlying)
Footnotes (5)
- [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F2]Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
- [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
- [F5]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001327414
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:57 PM ET
- Size
- 11.5 KB